Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 20/20 | 0.69 |
| ▸ | CASP7 | P55210 | 18/20 | 0.69 |
| ▸ | CASP6 | P55212 | 3/20 | 0.68 |
| ▸ | CASP2 | P42575 | 2/20 | 0.68 |
| ▸ | CASP1 | P29466 | 3/20 | 0.53 |
| ▸ | CASP9 | P55211 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535698 | 1.00 | CASP3 (0.69) | CASP3CASP7CASP6CASP2CASP1 | |
| SCHEMBL13925541 | 0.82 | CASP3 (0.78) | CASP3CASP7CASP6CASP1 | |
| SCHEMBL6535822 | 0.82 | CASP3 (0.70) | CASP3CASP7CASP6CASP2CASP1 | |
| SCHEMBL4156846 | 0.82 | CASP3 (1.00) | CASP3CASP7CASP6CASP2CASP1 | |
| SCHEMBL13925501 | 0.82 | CASP3 (1.00) | CASP3CASP7CASP6CASP2CASP1 | |
| SCHEMBL6535823 | 0.82 | CASP3 (0.70) | CASP3CASP7CASP6CASP2CASP1 | |
| SCHEMBL4156851 | 0.82 | CASP3 (1.00) | CASP3CASP7CASP6CASP2CASP1 | |
| SCHEMBL15029242 | 0.80 | CASP3 (1.00) | CASP3CASP7CASP1 | |
| SCHEMBL5184400 | 0.80 | CASP3 (1.00) | CASP3CASP7CASP1 | |
| SCHEMBL8263983 | 0.76 | CASP3 (0.67) | CASP3CASP7CASP6CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001933-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2002-11-06 | — | — | EP | claimed |
| EP-1001933-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999006367-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-02-11 | — | — | WO | claimed |
| EP-1242081-A4 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORP (US) | 2004-07-21 | — | — | EP | disclosed |
| EP-1242081-A1 | CASPASES AND APOPTOSIS | SmithKline Beecham Corporation (US) | 2002-09-25 | — | — | EP | disclosed |
| US-6403792-B1 | INHIBIT PRODUCTION OF CASPASE 3 AND 7 IN MAMMALS | SMITHKLINE BEECHAM CORPORATION | 2002-06-11 | — | — | US | disclosed |
| WO-2001022966-A1 | CASPASES AND APOPTOSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-04-05 | — | — | WO | disclosed |